A class of immune cells push themselves into an inflammatory state by producing large quantities of a serotonin-making enzyme, a finding that could inform future treatments for asthma and other allergic disorders.
Professionals from Cayuga Health have joined their Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center counterparts to care for New Yorkers diagnosed with COVID-19.
How individuals, and health care professionals, deal with infection from SARS-CoV-2, the virus that causes COVID-19, varies depending on the severity of the infection.
COVID-19 patients experience a wide range of disease severity. Why do some people get severe and life-threatening illness, while others suffer no symptoms or just mild ones?
The Partners of Citadel and Citadel Securities have made a $2 million gift to Weill Cornell Medicine to develop new approaches to protect people from COVID-19 and identify new cases of it.
Mathematical modeling by Weill Cornell Medicine is helping to guide New York state and New York City leaders as they make decisions that could affect the trajectory of the COVID-19 pandemic.
As hospitals and emergency departments urge more patients to stay home to avoid exposing themselves to COVID-19, patient care is moving to “telemedicine,” using web-based video and audio technology.
With the COVID-19 pandemic coinciding with the start of spring, you may be wondering when your respiratory symptoms indicate allergies – or something more serious.
While the traditional in-person Match Day celebration hosted on Weill Cornell Medicine’s campus was canceled due to COVID-19, fourth-year graduating students found creative ways to celebrate their accomplishments.
